Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Xometry $347.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
Brookfield Business Partners $3.4 billion acquisition of DexKo Global
We are advising Brookfield on the acquisition
Corporación Acciona Energías Renovables €1.3 billion IPO
We advised Corporación Acciona Energías Renovables on its IPO and Spanish Stock Exchanges listing
Elliott Opportunity II $609.5 million IPO
We advised Elliott Opportunity II Corp., a SPAC, on its IPO and NYSE listing
HUTCHMED HK$4.17 billion IPO and primary listing
The shares are listed on the Hong Kong Stock Exchange
Integral Ad Science Holding $270 million IPO
We advised the underwriters on the IPO and Nasdaq listing
XPO Logistics $794 million follow-on and secondary offering
We advised the underwriters on the SEC-registered stock offering
XTO Energy acquisition of royalty interest from Hugoton Royalty Trust
We are advising XTO on the transaction
Bowlero $2.6 billion merger with Isos Acquisition
We advised Atairos on the acquisition